JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (5): 81-84.doi: 10.6040/j.issn.1671-7554.0.2014.948

Previous Articles     Next Articles

A clinic research of amitriptyline in treatment of painful diabetic peripheral neuropathy

SUN Zhuohao1, LIU Yan2, ZHOU Dongmei3, LI Wei3   

  1. 1. Xuzhou Medical College, Xuzhou 221002, Jiangsu, China;
    2. Department of Radiology, Zaozhuang Fourth Municipal Hospital, Zaozhuang 277500, Shandong, China;
    3. Department of Endocrinology, the Affilicated Hospital of Xuzhou Medical College, Xuzhou 221000, Jiangsu, China
  • Received:2014-12-12 Revised:2015-03-25 Online:2015-05-10 Published:2015-05-10

Abstract: Objective To observe the clinical effect of amitriptyline on the treatment of painful diabetic peripheral neuropathy (PDPN). Methods A total of 104 patients with diabetic peripheral neuropathy (DPN) were randomly divided into the case group (n=52) and control group (n=52). The case group was treated with amitriptyline, mecobalamine and epalrestat; while the control group was just treated with mecobalamine and epalrestat. The treatment lasted for 12 weeks. Nerve conduction velocity, visual analogue scale (VAS) of the two groups were compared before and after the treatment. Results Compared with the control group, the nerve conduction velocity of the case group was faster and VAS decreased (P<0.05). Conclusion The effect of using amitriptyline in treatment of PDPN is better.

Key words: Amitriptyline, Diabetic peripheral neuropathy, Neuropathy pain

CLC Number: 

  • R589.1
[1] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in china[J]. N Engl J Med, 2010, 362(12):1090-1101.
[2] Farmer KL, Li C, Dobrowsky RT. Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?[J]. Pharmacol Rev, 2012, 64(4):880-900.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志, 2012, 20(1):S1-S37.
[4] Alverti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J] Diabet Med, 1998, 15(7):539-553.
[5] Herder C, Peltonen M, Koenig W, et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes results from the finnish diabetes prevention study[J]. Diabetes, 2006, 55(8):2340-2346.
[6] Abbott CA, Malik RA, van Ross ER, et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK[J]. Diabetes Care, 2011, 34(10):2220-2224.
[7] Habib AA, Brannagan TH 3rd. Therapeutic strategies for diabetic neuropathy[J]. Curr Neurol Neurosci Rep, 2010, 10(2):92-100.
[8] 周雁,郭立新,周璐,等.老年2型糖尿病患者周围神经病变的影响因素[J].山东大学学报:医学版, 2012, 50(6):1-4. ZHOU Yan, GUO Lixin, ZHOU Lu, et al. Factors influencing diabetic peripheral neuropathy in elderly type 2 diabetic patients[J]. Journal of Shandong University: Health Science, 2012, 50(6):1-4.
[9] Farghaly HS, Abd-Ellatief RB, Moftah MZ, et al. The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic painmodel[J]. Pain Physician, 2014, 17(2):187-195.
[10] 毛庆祥,杨天德.阿米替林抑制神经性疼痛大鼠脊髓星形胶质细胞的激活[J].第三军医大学学报, 2009, 31(7):611-614. MAO Qingxiang, YANG Tiande. Amitriptyline inhibits activation of astrocytes in spinal cord of rat with neuropathic pain[J]. Acta Academiae Medicinae Militaris Tertiae, 2009, 31(7):611-614.
[11] 王美娟.阿米替林治疗糖尿病周围神经性疼痛57例[J].中国药业, 2010, 19(7): 81-82.
[12] 刘鹏,胡小风,胡穗发,等.加味桃红四物汤联合小剂量阿米替林治疗糖尿病周围神经痛33例临床观察[J].中医药导报, 2013(5):64-66.
[13] 刘宪红,牛金葆.阿米替林联合α-硫辛酸治疗痛性糖尿病周围神经病变疗效观察[J].临床荟萃, 2013, 28(7):813-814.
[14] 张晓凡,李素霞,马沙.阿米替林联合α-硫辛酸治疗痛性糖尿病周围神经病变临床疗效[J].中国现代药物应用, 2014(17):11-12. ZHANG Xiaofan, LI Suxia, MA Sha. Clinical effect of amitriptyline combined with α-lipoicin in the treatment of painful diabetic peripheral neuropathy[J]. Chinese Journal of Modern Drug Application, 2014(17):11-12.
[15] 林夏鸿,陈晓毓,周竟雄,等.普瑞巴林治疗糖尿病痛性周围神经病变的疗效观察[J].中国糖尿病杂志, 2014, 22(8):707-710. LIN Xiahong, CHEN Xiaoyu, ZHOU Jingxiong, et al. Efficacy of pregabalin on diabetic peripheral neuropathy pain[J]. Chinese Journal of Diabetes, 2014, 22(8):707-710.
[16] 施君,张文川.糖尿病周围神经病变发病机制的研究进展[J].上海交通大学学报:医学版, 2012, 32(1):116-119. SHI Jun, ZHANG Wenchuan. Research progress of pathogenesis of diabetic peripheral neuropathy[J]. Journal of Shanghai Jiaotong University: Medical Science, 2012, 32(1):116-119.
[17] Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials[J]. N Engl J Med, 2008, 358(24):2630-2633.
[1] ZHANG Liang, XU Min, ZHUANG Xianghua, LOU Fuchen, LOU Nengjun, LÜ Li, GUO Wenjuan, ZHENG Fengjie, CHEN Shihong. An investigation of endoplasmic reticulum stress and apoptosis in diabetic peripheral neuropathy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 13-17.
[2] SHI Rui, SUN Pei, WANG Lulu, DING Lin, XIA Jin, WANG Yan, PANG Shuguang. Vitamin D and mecobalamin combined with mouse nerve growth factor for diabetic peripheral neuropathy: a clinical observation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(4): 64-67.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!